Measurement of the airway surface liquid volume with simple light refraction microscopy.
In the cystic fibrosis (CF) lung, the airway surface liquid (ASL) volume is depleted, impairing mucus clearance from the lung and leading to chronic airway infection and obstruction. Several therapeutics have been developed that aim to restore normal airway surface hydration to the CF airway, yet preclinical evaluation of these agents is hindered by the paucity of methods available to directly measure the ASL. Therefore, we sought to develop a straightforward approach to measure the ASL volume that would serve as the basis for a standardized method to assess mucosal hydration using readily available resources. Primary human bronchial epithelial (HBE) cells cultured at an air-liquid interface develop a liquid meniscus at the edge of the culture. We hypothesized that the size of the fluid meniscus is determined by the ASL volume, and could be measured as an index of the epithelial surface hydration status. A simple method was developed to measure the volume of fluid present in meniscus by imaging the refraction of light at the ASL interface with the culture wall using low-magnification microscopy. Using this method, we found that primary CF HBE cells had a reduced ASL volume compared with non-CF HBE cells, and that known modulators of ASL volume caused the predicted responses. Thus, we have demonstrated that this method can detect physiologically relevant changes in the ASL volume, and propose that this novel approach may be used to rapidly assess the effects of airway hydration therapies in high-throughput screening assays.
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Peter R
PR
Harvey
Robert
R
Tarran
Stephen
S
Garoff
Mike M
MM
Myerburg
D001980:Bronchi / Q000166:cytology*; D002460:Cell Line; D003550:Cystic Fibrosis / Q000473:pathology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D053503:Epithelial Sodium Channels / Q000378:metabolism; D006801:Humans; D007477:Ions; D008853:Microscopy / Q000379:methods*; D018613:Microscopy, Confocal / Q000379:methods; D009092:Mucous Membrane / Q000473:pathology; D015203:Reproducibility of Results; D013499:Surface Properties; D013997:Time Factors
D053503:Epithelial Sodium Channels; D007477:Ions; D019005:Cystic Fibrosis Transmembrane Conductance Regulator
Am J Respir Crit Care Med. 2007 Jul 15;176(2):167-73
17446335
Am J Respir Cell Mol Biol. 2010 Dec;43(6):712-9
20097829
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
19846789
J Gen Physiol. 2006 May;127(5):591-604
16636206
Am J Physiol. 1999 Apr;276(4):C827-37
10199813
Chest. 2008 Jun;133(6):1388-1396
18339790
Am J Respir Crit Care Med. 2008 Dec 15;178(12):1245-56
18849497
Cell. 1998 Dec 23;95(7):1005-15
9875854
J Clin Invest. 2002 Mar;109(5):571-7
11877463
Science. 1993 Oct 15;262(5132):424-7
8211164
Nat Med. 2004 May;10(5):487-93
15077107
J Clin Invest. 2008 Dec;118(12):4025-35
19033671
J Biol Chem. 2005 Oct 21;280(42):35751-9
16087672
N Engl J Med. 1981 Dec 17;305(25):1489-95
7300874
J Clin Invest. 1998 Sep 15;102(6):1125-31
9739046
Thorax. 2010 Jan;65(1):51-6
19996349
Mol Cell. 2001 Jul;8(1):149-58
11511368
J Pharmacol Exp Ther. 2004 Dec;311(3):929-38
15273255
Pulm Pharmacol Ther. 2010 Aug;23(4):268-78
20226262
N Engl J Med. 1993 Oct 28;329(18):1308-13
8166795
Curr Opin Pharmacol. 2010 Jun;10(3):294-9
20439165
Am J Respir Crit Care Med. 2007 Aug 15;176(4):362-9
17446337
J Gen Physiol. 2001 Aug;118(2):223-36
11479349
J Pharmacol Exp Ther. 2008 Apr;325(1):77-88
18218832
Pediatr Pulmonol. 2005 Apr;39(4):339-48
15704203
N Engl J Med. 2006 Jan 19;354(3):241-50
16421365
Am J Respir Cell Mol Biol. 2010 Jan;42(1):105-12
19346319
J Clin Invest. 2000 May;105(10):1419-27
10811849
J Pharmacol Exp Ther. 2009 May;329(2):764-74
19190233
J Pharmacol Exp Ther. 2000 Feb;292(2):778-87
10640318
N Engl J Med. 2006 Jan 19;354(3):229-40
16421364
J Biol Chem. 2006 Sep 22;281(38):27942-9
16873367
Nat Chem Biol. 2010 Jan;6(1):25-33
19966789